JuradoRomanAlfonso (@juradoromanal) 's Twitter Profile
JuradoRomanAlfonso

@juradoromanal

Interventional Cardiologist. MD, PhD. ComplexPCI-CTO Operator. Stuctural Interventions. Research and Education.

ID: 1756010134155694080

calendar_today09-02-2024 17:40:33

469 Tweet

448 Followers

531 Following

European Society of Cardiology Journals (@esc_journals) 's Twitter Profile Photo

Benefit of isolated surgical valve repair or replacement for functional #TricuspidRegurgitation and long-term outcomes stratified by the #TRISCORE released at #ESCCongress and just published in #EHJ👉 bit.ly/4g6TR0b EHJ Editor-in-Chief Dreyfus Julien Fernando M. Juarez-Casso

Benefit of isolated surgical valve repair or replacement for functional #TricuspidRegurgitation and long-term outcomes stratified by the #TRISCORE released at #ESCCongress and just published in #EHJ👉 bit.ly/4g6TR0b

<a href="/ehj_ed/">EHJ Editor-in-Chief</a> <a href="/juliendreyfus1/">Dreyfus Julien</a> <a href="/FernandoM_JC/">Fernando M. Juarez-Casso</a>
RTHahnMD (@hahn_rt) 's Twitter Profile Photo

RESHAPE-HF2 shows no impact on mortality but significant reduction in HFH and improvement in KCCQ. All call for a larger trial to confirm MTEER for lower risk and lower MR severity. #ESC2024

European Society of Cardiology (@escardio) 's Twitter Profile Photo

#ESCCongressVisuals for Hotline 4 ASSURE DES - Perioperative antiplatelet therapy in patients with coronary stents before non-cardiac surgery SWEDEGRAFT - No-touch vein grafts in coronary artery bypass grafting The TIGHT-K trial - Potassium supplementation and the

#ESCCongressVisuals for Hotline 4
 
ASSURE DES - Perioperative antiplatelet therapy in patients with coronary stents before non-cardiac surgery
 
SWEDEGRAFT - No-touch vein grafts in coronary artery bypass grafting
 
The TIGHT-K trial - Potassium supplementation and the
Enrique Santas (@santasenrique) 's Twitter Profile Photo

FINE-HEART Finerenone across the cardio-kidney-metabolic spectrum Muthu Vaduganathan European Society of Cardiology #ESCCongress 18,991 👥 in FIDELIO-DKD, FIGARO-DKD, FINEARTS-HF trials ▶️ Non-significant ⤵️ in CV death (HR 0.89; p= 0.076) but: ▶️ Consistent clinical benefits, with ⤵️ in all-cause

FINE-HEART Finerenone across the cardio-kidney-metabolic spectrum <a href="/mvaduganathan/">Muthu Vaduganathan</a> <a href="/escardio/">European Society of Cardiology</a> #ESCCongress 

18,991 👥 in FIDELIO-DKD, FIGARO-DKD, FINEARTS-HF trials 

▶️ Non-significant ⤵️ in CV death (HR 0.89; p= 0.076) but: 

▶️ Consistent clinical benefits, with ⤵️ in all-cause
European Society of Cardiology (@escardio) 's Twitter Profile Photo

#ESCCongressVisuals for Hotline 7: FINEARTS-HF - #Finerenone in #HeartFailure with mildly reduced and preserved ejection fraction MRAs in #HF - An individual patient data meta-analysis of randomised trials FINE-HEART - Participant-level pooled analysis of finerenone in

#ESCCongressVisuals for Hotline 7:
 
FINEARTS-HF - #Finerenone in #HeartFailure with mildly reduced and preserved ejection fraction
 
MRAs in #HF - An individual patient data meta-analysis of randomised trials
 
FINE-HEART - Participant-level pooled analysis of finerenone in
C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

Microvascular resistance reserve (MRR) associated with rates of angina after revascularization in pts with moderate coronary stenosis beyond CRF or FFR. Watch Dr. Laust Dupont Rasmussen present results of Dan-NICAD study presented at #ESCCongress

C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

Download slides presented at #ESCCongress for Dan-NICAD for microvascular resistance reserve and health-status outcomes after revascularization in pts with moderate coronary stenosis clinicaltrialresults.org/wp-content/upl…

Download slides presented at #ESCCongress for Dan-NICAD for microvascular resistance reserve and health-status outcomes after revascularization in pts with moderate coronary stenosis clinicaltrialresults.org/wp-content/upl…
C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

Reconciling results from ECLS-SHOCK trial for VA-ECMO vs. DANGER SHOCK trial for Impella - are the differing results due to device differences or due to patient selection differences? Watch Dr. Thiele and I discuss findings #ESCCongress

C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

In patients with AMI and cardiogenic shock with planned revascularization, routine early MCS does not reduce 6-month all-cause mortality irrespective of device type. Higher rate of bleeding and peripheral complications with MCS #ESCCongress

In patients with AMI and cardiogenic shock with planned revascularization, routine early MCS does not reduce 6-month all-cause mortality irrespective of device type. Higher rate of bleeding and peripheral complications with MCS #ESCCongress
C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

Meta-analysis of RCTs showed routine early MCS did not reduce 6-months mortality in pts with AMI and cardiogenic shock with planned revasc, potential benefit may be only in STEMI and low-risk of hypoxic brain injury. Dr. Thiele presents meta-analysis at #ESCCongress

C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

Routine temporary MCS in infarct-related cardiogenic shock does not improve 6-months outcomes, meta-analysis shows. Download slides from meta-analysis here clinicaltrialresults.org/wp-content/upl… #ESCCongress

Routine temporary MCS in infarct-related cardiogenic shock does not improve 6-months outcomes, meta-analysis shows. Download slides from meta-analysis here clinicaltrialresults.org/wp-content/upl… #ESCCongress
Giuseppe Biondi-Zoccai (@gbiondizoccai) 's Twitter Profile Photo

In the SEQUOIA-HCM RCT, adult patients with symptomatic obstructive hypertrophic cardiomyopathy receiving aficamten demonstrated significant improvement in LVOT gradients and measures of LV diastolic function in comparison to those receiving placebo, and these changes were

In the SEQUOIA-HCM RCT, adult patients with symptomatic obstructive hypertrophic cardiomyopathy receiving aficamten demonstrated significant improvement in LVOT gradients and measures of LV diastolic function in comparison to those receiving placebo, and these changes were
REC Publications (@revespcardiol) 's Twitter Profile Photo

A Debate! 📣#recintervcardiol Ablación frente a litotricia en lesiones coronarias calcificadas. 🚨 Perspectiva desde la litotricia Belén Cid Alvarez recintervcardiol.org/es/debate/a-de… 🚨 Perspectiva desde la ablación JuradoRomanAlfonso recintervcardiol.org/es/debate/a-de…

REC Publications (@revespcardiol) 's Twitter Profile Photo

Intervención coronaria percutánea guiada por tomografía de coherencia óptica frente a guiada por ecografía intravascular en pacientes con infarto agudo de miocardio #REC revespcardiol.org//es-intervenci…

Intervención coronaria percutánea guiada por tomografía de coherencia óptica frente a guiada por ecografía intravascular en pacientes con infarto agudo de miocardio #REC revespcardiol.org//es-intervenci…
Cardiología La Paz (@cardiohulp) 's Twitter Profile Photo

👤 Varón de 71 años. Dislipidemia, exfumador. Episodios de dolor torácico de repetición, sobre todo nocturnos 💊 Adiro, Bisoprolol 2.5 mg y Atorvastatina 80 mg 🩻 Eco de esfuerzo: negativo Se cita finalmente para coronariografía en Hemodinamica_LaPaz ...

Evandro Martins F. MD (@evandrofilhobr) 's Twitter Profile Photo

Felipe Díez del Hoyo JuradoRomanAlfonso Creo que detrás de una PCI compleja generalmente hay un paciente complejo. Mi pregunta es la misma que la suya, PCI complejo versus no PCI. ¿A qué hora? Y el impacto del tipo de válvula y la commissural alignment... son preguntas que deben responderse.

ACI-SEC: Hemodinamica (@shci_sec) 's Twitter Profile Photo

Registro español de hemodinámica y cardiología intervencionista. XXXIII informe oficial de la Asociación de Cardiología Intervencionista de la Sociedad Española de Cardiología (1990–2023) revespcardiol.org/es-registro-es… Teresa Bastante Dabit Arzamendi Belén Cid Alvarez Javi Moreiras Soc Esp Cardiología

Miguel Corbí (@corbi_miguel) 's Twitter Profile Photo

Comienza la cuenta atrás... Mucha ilusión... Muchos preparativos... Mucho trabajo... Pero seguro que vale la pena!!! Nos vemos en una semana!!! ☺😊🙂🙃😉 #cardiocete24